Oxidative Stress

Overview

Oxidative stress occurs when the production of reactive oxygen species (ROS) overwhelms the body's antioxidant defense systems, resulting in damage to lipids, proteins, and DNA. While ROS at low concentrations serve essential signaling functions, excessive or uncontrolled ROS production drives molecular damage that accumulates with age and contributes to nearly every chronic disease.

The concept of oxidative stress as a driver of aging was first proposed in Denham Harman's free radical theory of aging (1956). While the theory has been refined considerably, the fundamental observation that oxidative damage accumulates with age and correlates with tissue dysfunction remains one of the most robust findings in aging biology.

How It Works

ROS generation occurs primarily in mitochondria during oxidative phosphorylation. Electron leak from Complex I and Complex III of the electron transport chain reduces molecular oxygen to superoxide (O2-), the precursor of other ROS. Additional sources include NADPH oxidases (in immune cells and vasculature), xanthine oxidase, cytochrome P450 enzymes, and peroxisomes. Under pathological conditions such as ischemia-reperfusion injury, inflammation, or mitochondrial dysfunction, ROS production can increase dramatically.

Superoxide is converted to hydrogen peroxide (H2O2) by superoxide dismutase (SOD). H2O2, while less reactive, can cross membranes and, in the presence of transition metals (iron, copper), generate the highly destructive hydroxyl radical (OH-) via the Fenton reaction. This radical attacks nearby molecules with near-diffusion-limited reactivity.

The antioxidant defense system operates at multiple levels. Enzymatic defenses include SOD (superoxide removal), catalase (H2O2 decomposition), glutathione peroxidase (GPx, reduces peroxides using glutathione), and the thioredoxin system. Non-enzymatic antioxidants include glutathione (the most abundant intracellular antioxidant), vitamin C, vitamin E, coenzyme Q10, and uric acid. The Nrf2-Keap1 pathway serves as the master regulator of antioxidant gene expression, activated by oxidative stress itself to mount a protective response.

Oxidative damage manifests across all macromolecule classes. Lipid peroxidation generates malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), which crosslink proteins and damage membranes. Protein oxidation produces carbonyl groups that alter enzyme function and promote aggregation. DNA oxidation generates 8-oxo-deoxyguanosine (8-oxo-dG), a mutagenic lesion that accumulates in both nuclear and mitochondrial DNA. These damage products serve as biomarkers of oxidative stress in clinical and research settings.

Key Components

• Superoxide (O2-): Primary ROS produced by mitochondria and NADPH oxidases; converted to H2O2 by SOD.
• Hydroxyl Radical (OH-): Most reactive ROS, generated via Fenton chemistry; damages all nearby macromolecules.
• Glutathione (GSH/GSSG): Principal intracellular antioxidant buffer; the GSH/GSSG ratio reflects cellular redox status.
• Nrf2: Transcription factor that upregulates hundreds of antioxidant and cytoprotective genes; considered the master regulator of the oxidative stress response.
• 8-oxo-dG: Oxidized guanine base in DNA; the most commonly measured biomarker of oxidative DNA damage.

Peptide Connections

• SS-31 (Elamipretide) targets the inner mitochondrial membrane, stabilizing cardiolipin and reducing electron leak from the ETC. By addressing ROS at their primary source, SS-31 reduces oxidative stress from within the mitochondria rather than attempting to scavenge radicals after they have been produced.

• Glutathione Peptides directly supplement the body's principal antioxidant. Reduced glutathione (GSH) is a tripeptide (gamma-glutamyl-cysteinyl-glycine) that neutralizes ROS, regenerates other antioxidants, and supports detoxification pathways. Declining GSH levels with age contribute to increased oxidative vulnerability.

• BPC-157 has demonstrated protective effects against oxidative damage in multiple preclinical models, including ischemia-reperfusion injury and toxin exposure. Its mechanisms may involve modulation of nitric oxide pathways and upregulation of endogenous antioxidant systems.

Clinical Significance

Oxidative stress is implicated in the pathogenesis of atherosclerosis (LDL oxidation), neurodegeneration (protein aggregation in Alzheimer's and Parkinson's), cancer (DNA mutagenesis), diabetes (beta cell damage), and chronic kidney disease. However, clinical trials of simple antioxidant supplementation have largely failed to prevent disease, revealing that the relationship between ROS and health is more nuanced than simple damage. Current understanding emphasizes the importance of maintaining redox signaling while preventing pathological ROS accumulation, rather than indiscriminately suppressing all oxidant production.

Related Topics

• Mitochondrial Dysfunction
• Telomere Shortening
• Glycation and AGEs
• Epigenetic Aging